Benjamin P Geisler, MD, MPH, MRCP (London) - Massachusetts General Hospital/Harvard Medical School

Benjamin P Geisler

MD, MPH, MRCP (London)

Massachusetts General Hospital/Harvard Medical School

Boston, MA | United States

Main Specialties: Internal Medicine

Additional Specialties: Hospital Medicine

ORCID logohttps://orcid.org/0000-0003-1704-6067


Top Author

Benjamin P Geisler, MD, MPH, MRCP (London) - Massachusetts General Hospital/Harvard Medical School

Benjamin P Geisler

MD, MPH, MRCP (London)

Introduction

Benjamin Geisler, M.D., M.P.H. is a board-certified internist who practices hospital medicine at Massachusetts General Hospital. He is an international medical graduate from Germany (Charite - Universitaetsmedizin Berlin) and completed a categorical internal medicine residency at NYU School of Medicine in New York City, NY. Prior to clinical training, Ben was a Post-doctoral Research Fellow in decision science at Massachusetts General Hospital and also completed a Master's degree in Public Health at the Harvard T.H. Chan School of Public Health.

As a general medicine doctor, he embraces coordinating clinical care for his patients between the inpatient and outpatient settings and among treating subspecialists. Ben individualizes evidence-based practices, takes patients' preference into account, practices shared medical decision making, and aims to increase the efficiency or value of health care services to provide highly patient- and family-centered care. He is particularly interested in cardiovascular diseases and their prevention, antimicrobial prescribing, rare diseases and diagnostic dilemmas across medical sub-specialties.

Ben is also a health services researcher, decision-analytic modeler, and health economist; he served as a co-editor of a peer-reviewed journal in those fields, Value in Health, for eight years and is currently on the editorial boards of Pharmacoeconomics and PLOS One. His research had applications across medical conditions although most were in cardiovascular disease. Ben enjoys teaching as well as running quality improvement/patient safety (QI/PS) projects. Recently, Ben has become interested in "big data" and how to use routinely collected health information for research and QI/PS.

Ben's ultimate career goal is to be an active citizen in the academic hospital medicine community.

Primary Affiliation: Massachusetts General Hospital/Harvard Medical School - Boston, MA , United States

Specialties:

Additional Specialties:

Research Interests:


View Benjamin P Geisler’s Resume / CV

Education

Charite Universitätsmedizin Berlin
MD
Harvard University
MPH

Experience

Jan 2012 - Jan 2015
New York University

Internal Medicine
Jan 2015
Massachusetts General Hospital

Hospital Medicine Group
Jan 2015
Harvard Medical School
Jan 2009
Wing Tech Inc.

Publications

40Publications

317Reads

16Profile Views

101PubMed Central Citations

Cost-Effectiveness of Transcatheter versus Surgical Aortic Valve Replacement inPatients at Lower Surgical Risk: Results from the NOTION Trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

AIMS:To estimate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) vs surgical aortic valve replacement (SAVR) in patients at lower surgical risk. METHODS AND RESULTS:Discounted costs from a societal perspective and effectiveness as quality-adjusted life years (QALYs) were projected to lifetime via a decision-analytic model calibrated to 60-month data from the NOTION trial. The base case assumed a scenario in which any mortality benefit would gradually fade out over time, with other scenarios explored in sensitivity analyses. The incremental cost-effectiveness ratio (ICER) was compared to the country-specific willingness-to-pay (WTP) threshold of 1.13 million Danish kroner (DKK).The base case ICER was DKK696,264/QALY (around €72,100/QALY via purchasing parity adjustment). Variation in long-term mortality beyond 5 years led to limited variation of incremental costs (DKK64,200 to 64,600), but a more pronounced variation in incremental QALYs (0.07 to 0.19 QALYs for most conservative and optimistic assumptions, compared to base case of 0.09 QALYs). All resulting ICERs (range DKK334,200 to DKK904,100 per QALY gained) were below the WTP threshold. CONCLUSIONS:TAVI in a cohort of primarily low-surgical-risk patients was found to be a cost-effective treatment strategy in the Danish healthcare system. Cost-effectiveness analyses in other settings are warranted as are registries given the sensitivity of the model to long-term mortality.

https://doi.org/10.4244/EIJ-D-18-00847

View Article
August 2019
1 Read

Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes.

J Hosp Infect 2019 Aug 27;102(4):438-444. Epub 2019 Mar 27.

Wing Tech Inc., Menlo Park, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhin.2019.03.012DOI Listing
August 2019
15 Reads
2.544 Impact Factor

Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting.

Respiration 2019 28;98(1):38-47. Epub 2019 Mar 28.

Institute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000497101DOI Listing
March 2019
9 Reads
2.593 Impact Factor

Correction to: Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan.

Cardiovasc Interv Ther 2018 Oct;33(4):337

Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, FALK CVRB CV-007, Stanford, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12928-017-0492-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153887PMC
October 2018
7 Reads

Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan.

Cardiovasc Interv Ther 2018 Oct 5;33(4):328-336. Epub 2017 Sep 5.

Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, FALK CVRB CV-007, Stanford, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12928-017-0488-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153894PMC
October 2018
60 Reads

Adoption Patterns of Bronchoscopic Lung Volume Reduction Procedures in Germany and Predicted Procedure Volumes for Other European Countries.

Respiration 2019;97(1):34-41. Epub 2018 Aug 17.

Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center Heidelberg, Member of the German Lung Research Network, Heidelberg,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000491677DOI Listing
August 2018
10 Reads
2.593 Impact Factor

Dyspnea and Chest Pain in a Young Woman Caused by a Giant Pericardial Lymphohemangioma: Diagnosis and Treatment.

Can J Cardiol 2016 10 9;32(10):1260.e23-1260.e25. Epub 2015 Dec 9.

Leon H. Charney Division of Cardiology, Department of Medicine, New York University Langone Medical Center, New York University School of Medicine, New York, New York, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2015.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993682PMC
October 2016
23 Reads
3.711 Impact Factor

Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.

BMJ Open 2016 05 9;6(5):e011245. Epub 2016 May 9.

Wing Tech Inc., Menlo Park, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2016-011245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874117PMC
May 2016
8 Reads
7 Citations
2.063 Impact Factor

Cardiovascular Benefits of the Mediterranean Diet Are Driven by Stroke Reduction and Possibly by Decreased Atrial Fibrillation Incidence.

Am J Med 2016 Jan;129(1):e11

NYU School of Medicine, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2015.04.046DOI Listing
January 2016
1 Citation
5.003 Impact Factor

Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study.

Clin Res Cardiol 2015 Apr 18;104(4):304-9. Epub 2014 Nov 18.

Institute for Health Care Management and Research, University Duisburg-Essen, Schützenbahn 70, 45127, Essen, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-014-0781-4DOI Listing
April 2015
23 Reads
1 Citation
4.560 Impact Factor

Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome.

J Immunother Cancer 2015 17;3. Epub 2015 Feb 17.

New York University School of Medicine, New York, NY 10016 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0048-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335413PMC
February 2015
9 Reads
6 Citations

Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.

Catheter Cardiovasc Interv 2014 Oct 27;84(4):546-54. Epub 2014 May 27.

Wing Tech Inc., Menlo Park, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25536DOI Listing
October 2014
48 Reads
8 Citations
2.110 Impact Factor

Gabapentin treatment for alcohol dependence.

JAMA Intern Med 2014 Jul;174(7):1201

Department of Medicine, NYU School of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2014.1618DOI Listing
July 2014
5 Reads

Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

J Am Coll Cardiol 2012 Oct 12;60(14):1271-7. Epub 2012 Sep 12.

Wing Tech Inc., Menlo Park, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2012.07.029DOI Listing
October 2012
5 Reads
20 Citations
16.503 Impact Factor

Trauma and burn education: a global survey.

World J Surg 2012 Mar;36(3):548-55

Department of Surgery, University of Washington, Box 325796, 325 Ninth Avenue, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-011-1419-6DOI Listing
March 2012
1 Read
1 Citation
2.642 Impact Factor

Use of observation care in US emergency departments, 2001 to 2008.

PLoS One 2011 14;6(9):e24326. Epub 2011 Sep 14.

Brigham and Women's Hospital-Massachusetts General Hospital-Harvard Affiliated Emergency Medicine Residency, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024326PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173457PMC
February 2012
3 Reads
25 Citations
3.234 Impact Factor

Determining health-related quality of life and health state utility values of urinary incontinence in women.

Female Pelvic Med Reconstr Surg 2011 Nov;17(6):305-7

From the *UMass Memorial Medical Center, Division of Urogynecology, Worcester; and †Brigham and Women's Hospital, Division of Urogynecology, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SPV.0b013e31823c040DOI Listing
November 2011
2 Reads

Decision-analytic models to simulate health outcomes and costs in heart failure: a systematic review.

Pharmacoeconomics 2011 Sep;29(9):753-69

Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02214, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.2165%2F11585990-0000
Web Search
http://link.springer.com/10.2165/11585990-000000000-00000
Publisher Site
http://dx.doi.org/10.2165/11585990-000000000-00000DOI Listing
September 2011
23 Reads
5 Citations
2.450 Impact Factor

Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.

Value Health 2011 Jun;14(4):607

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2011.01.003DOI Listing
June 2011
4 Reads
3.280 Impact Factor

Leadership in health care: developing a post-merger strategy for Europe's largest university hospital.

J Health Organ Manag 2010 ;24(3):258-76

Harvard School of Public Health, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1108/14777261011054608DOI Listing
October 2010
13 Reads
1 Citation

Health state survey-derived utilities in cost-utility analysis--a call to action.

Value Health 2010 Mar-Apr;13(2):159. Epub 2009 Nov 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4733.2009.00665.xDOI Listing
September 2010
5 Reads
3.280 Impact Factor

Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents.

Expert Opin Biol Ther 2010 Aug;10(8):1209-16

Massachusetts General Hospital, Institute for Technology Assessment, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2010.500282DOI Listing
August 2010
5 Reads
3 Citations
3.743 Impact Factor

Estimates of electronic medical records in U.S. Emergency departments.

PLoS One 2010 Feb 17;5(2):e9274. Epub 2010 Feb 17.

Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009274PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822862PMC
February 2010
5 Reads
4 Citations
3.234 Impact Factor

Deterministic sensitivity analysis for first-order Monte Carlo simulations: a technical note.

Value Health 2009 Jan-Feb;12(1):96-7. Epub 2008 Jul 18.

Institute for Technology Assessment, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4733.2008.00411.xDOI Listing
November 2009
4 Reads
3.280 Impact Factor

Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations.

Value Health 2009 Jan-Feb;12(1):185-7. Epub 2008 Jul 18.

Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4733.2008.00425.xDOI Listing
November 2009
7 Reads
15 Citations
3.280 Impact Factor

Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure.

Eur J Heart Fail 2008 Oct 28;10(10):1026-32. Epub 2008 Aug 28.

Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-4724, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejheart.2008.07.018DOI Listing
October 2008
4 Reads
4 Citations
6.530 Impact Factor

Top co-authors

Jan B Pietzsch
Jan B Pietzsch

Stanford University

7
Uwe Siebert
Uwe Siebert

Institute of Public Health

5
Alexander Goehler
Alexander Goehler

Massachusetts General Hospital

2
Fumiaki Ikeno
Fumiaki Ikeno

Stanford University

2
Jennifer M Manne
Jennifer M Manne

Harvard Medical School

2
Jeremiah D Schuur
Jeremiah D Schuur

Brigham and Women's Hospital

2